Poison control centers in the US have seen a dramatic rise in reports of children ingesting melatonin over the last decade.
From 2012 to 2021, these incidents increased 530 percent, according to a study from the Centers for Disease Control and Prevention released Thursday. The largest annual increase occurred from 2019 to 2020, when reported spiked by 38 percent.
Melatonin is a hormone that can help regulate sleep. It’s also produced and sold as a dietary supplement in pill, liquid or gummy form. Melatonin sales rose 150 percent in the US between 2016 and 2020, according to the CDC.
The agency said that most poison control reports came after children took melatonin supplements accidentally. Less than 6 percent of the ingestions were intentional, meaning that either parents gave melatonin to kids or older children took too much on purpose.
“This might be related to increased accessibility of melatonin during the pandemic, as children spent more time at home because of stay-at-home orders and school closures,” the CDC report said. “Further, reports of increasing sleep disturbances during the pandemic might have led to increased availability of melatonin in the home.”
A survey of mostly US residents found that worries about Covid-19 were a consistent predictor of insomnia.
In total, poison control centers received more than 260,000 reports of children ingesting melatonin over 10 years. Most children did not need to go to the hospital, but more than 4,000 were hospitalized, and the number of cases requiring hospitalization rose over the study period.
Five children were placed on ventilators. Two of those children, ages 3 months and 13 months, died.
“It’s wholly predictable that as a drug becomes more available and accessible in homes, more poisoning events will occur,” Dr. Kevin Osterhoudt, medical director of the Poison Control Center at Children’s Hospital of Philadelphia, said.
Melatonin gummies may look particularly attractive to young kids, according to Dr. George Wang, a pediatric emergency medicine physician at Children’s Hospital Colorado.
“Many of them are not in any child-resistant packaging,” Wang said. “There’s no regulations on how they should be packaged. A child could get into a significant amount of them.”
Symptoms of melatonin ingestion in children
Osterhoudt said his hospital has seen “a huge rise in melatonin ingestions and melatonin exposures,” so the CDC report “corroborated what we felt we’d been seeing at the bedside.”
Most melatonin-related calls to poison control centers were likely precautionary, he said, since 83 percent of the children in the study had no symptoms. Even among hospitalized patients, he added, symptoms are usually mild.
“Sleepiness is common. Headaches and restlessness are common,” Osterhoudt said. “We’ll get many people who will say they get an upset stomach, vomiting or diarrhea or nausea.”
But in more severe cases, children may fall into a coma and stop breathing properly.
“That’s where these dangerous outcomes happen,” Wang said.
But the experts said it typically requires a large dose of melatonin to cause those serious effects.
“If you double dose, even triple dose, it probably won’t lead to a significant adverse event,” Wang said. “So these more severe effects, even deaths in these children that are reported, I anticipate probably were quite large ingestions.”
In one of the deaths, he said, “there was even reported malicious use, probably someone trying to sedate a child on purpose.”
It’s possible there were other confounding factors in severe cases, Osterhoudt said, but the report didn’t include that information.
Is it ever safe for children to take melatonin?
Most of the reports in the CDC study were about children age 5 or younger, and 99 percent of cases occurred at home. Given that, both experts said, the trend is likely to result in more parents purchasing melatonin supplements and storing them in places children can reach.
“One year to 4 years — those are the curious years,” Osterhoudt said. “That’s when children can now walk and climb and get into places that their parents weren’t ready for them to get into. So they find things and explore the world by putting things into their mouths.”
Since melatonin is considered a dietary supplement in the US, it does not require approval from the Food and Drug Administration and can be purchased over the counter.
Because of that lack of regulation, Osterhoudt said, “often times the amount of melatonin in the products will be less or more than we think that we’re getting.”
There’s also a possibility of “other ingredients in the pill or the liquid that we’re taking that we are unaware of and that aren’t disclosed on the label,” he added.
That can make it difficult to determine how much melatonin a child has actually ingested.
There’s also still a debate about melatonin’s effectiveness for kids and adults.
“It is thought that short-term use of melatonin can be helpful in treating people with sleep disorders or jetlag,” Osterhoudt said, though he added that “we could use more research on how supplementing these hormones over long periods of time might affect the body.”
A 2018 study found that melatonin improved the sleep patterns of people ages 16 to 65 who had difficulty falling asleep or waking at normal hours. But a 2017 task force from the American Academy of Sleep Medicine did not recommend melatonin for adults with insomnia.
When it comes to kids, a 2020 study found that melatonin helped them fall asleep and sleep longer but did not reduce the number of times they woke up in the night.
Wang said pediatricians typically advise behavioral changes like reducing screen time before bed or sticking to regular bedtimes over melatonin.
For parents who opt to give children melatonin, the American Academy of Pediatrics recommends a low dose of 0.5 to 1 milligrams 30 to 90 minutes before bedtime. Dosage should not exceed 3 to 6 milligrams, the guidelines say, but experts still want more clarity.
“We need more research to define how much is too much,” Osterhoudt said.
George is Digismak’s reported cum editor with 13 years of experience in Journalism